CLINICAL_TRIALS
research
· 2018-06-28
Clinical Trial Update: Rhythmic Risk of Type 1 Brugada Syndrome and Pulmonary Infundibulum Mapping [NA]
Summary
A clinical trial update focusing on rhythmic risk in Brugada syndrome and mapping of the pulmonary infundibulum.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hospices Civils de Lyon | Conditions: Brugada Syndrome Type 1 | NA | Status: UNKNOWN